Towards Precision Therapy in Hepatocellular Carcinoma: A Clinical-Reasoning LLM for Risk Stratification and Treatment Guidance

• URL: http://arxiv.org/abs/2607.08602v1
• Date: Thu, 09 Jul 2026 15:33:08 GMT
• Title: Towards Precision Therapy in Hepatocellular Carcinoma: A Clinical-Reasoning LLM for Risk Stratification and Treatment Guidance
• Abstract summary: We present HCC-STAR (Hepatocellular Carcinoma Staging, Treatment And pRognosis), a clinically aligned large language model.<n>It outputs risk score-based staging, ranked guideline-consistent treatments with evidence-based rationales, and individualized survival estimates.<n>In a multi-center cohort of 6,668 patients from 12 hospitals in China, HCC-STAR achieved state-of-the-art performance in treatment recommendation and risk stratification.
• Score: 69.07885031885303
• License: http://creativecommons.org/licenses/by/4.0/
• Abstract: Hepatocellular carcinoma (HCC) is a common malignancy and a leading cause of cancer-related mortality. Current guidelines and staging systems provide coarse categories, but often miss within-stage heterogeneity and the clinical context in electronic medical records (EMRs). We present HCC-STAR (Hepatocellular Carcinoma Staging, Treatment And pRognosis), a clinically aligned large language model that reads routine EMR narratives and jointly outputs risk score-based staging, ranked guideline-consistent treatments with evidence-based rationales, and individualized survival estimates. We curated about 30,000 HCC cases from SEER and expanded them into EMR-style narrative training data using a clinician-validated, prompt-based augmentation workflow. On this corpus, we developed a knowledge-aligned reasoning framework optimized with a step-verifiable composite reward, moving beyond text-level memorization of clinical guidelines. In a multi-center cohort of 6,668 patients from 12 hospitals in China, HCC-STAR achieved state-of-the-art performance in treatment recommendation and risk stratification compared with clinical guidelines and competitive models, including GPT-5 and Gemini-2.5 Pro. Hypothetical overall-survival analysis showed a median survival of 51 months under adherence to HCC-STAR recommendations, compared with 29 and 32 months under BCLC and CNLC. In clinician-centric evaluations, blinded hepatobiliary specialists rated HCC-STAR's reasoning and evidence-based justifications as trustworthy. The model surpassed resident and attending physicians in treatment accuracy and helped physicians make more accurate decisions faster when used as an assistant. These findings support HCC-STAR as a reliable and verifiable decision-support system for risk stratification and precision therapy in HCC.

Related papers

• A Breast Vision Pathology Foundation Model for Real-world Clinical Utility [65.57568187389113]
  We present bfBRAVE, a breast-adaptive pathology foundation model developed and evaluated using a total resource of 101,638 breast wholeslide images.<n>BRAVE supported practical roles in the clinical workflow, including safe exclusion of low-risk cases from routine AI-assisted second-review rescue of initially missed positives and prioritization of cases for further assessment.
  arXiv  Detail & Related papers  (2026-05-06T07:44:39Z)
• Improving Risk Stratification in Hypertrophic Cardiomyopathy: A Novel Score Combining Echocardiography, Clinical, and Medication Data [0.3611680827515096]
  Hypertrophic cardiomyopathy (HCM) requires accurate risk stratification to inform decisions regarding ICD therapy and follow-up management.<n>This study develops a robust, explainable machine learning (ML) risk score to predict a 5-year composite cardiovascular outcome in HCM patients.<n>The model high interpretability and its capacity for longitudinal risk monitoring represent promising tools for the personalized clinical management of HCM.
  arXiv  Detail & Related papers  (2026-03-27T10:22:46Z)
• Clinical Reasoning AI for Oncology Treatment Planning: A Multi-Specialty Case-Based Evaluation [0.7695487047291749]
  More than 80% of U.S. cancer care is delivered in community settings.<n>Clinicians must integrate genomics, staging, pathology, and changing guidelines, creating cognitive burden.<n>We evaluated OncoBrain, an AI clinical reasoning platform for oncology treatmentplan generation.
  arXiv  Detail & Related papers  (2026-03-27T00:26:05Z)
• A Decade-Scale Benchmark Evaluating LLMs' Clinical Practice Guidelines Detection and Adherence in Multi-turn Conversations [60.2076951536797]
  Large Language Models (LLMs) are increasingly deployed in healthcare scenarios.<n>It is unclear to which extend LLMs could identify and adhere to clinical guidelines during conversations.<n>CPGBench is an automated framework benchmarking the clinical guideline detection and adherence capabilities of LLMs.
  arXiv  Detail & Related papers  (2026-03-26T09:00:55Z)
• CancerGUIDE: Cancer Guideline Understanding via Internal Disagreement Estimation [18.396334867873307]
  National Comprehensive Cancer Network (NCCN) provides evidence-based guidelines for cancer treatment.<n>Translating complex patient presentations into guideline-compliant treatment recommendations is time-intensive, requires specialized expertise, and is prone to error.<n>We present an agent-based approach to automatically generate guideline-concordant treatment trajectories for patients with non-small cell lung cancer.
  arXiv  Detail & Related papers  (2025-09-09T01:49:29Z)
• LGE-Guided Cross-Modality Contrastive Learning for Gadolinium-Free Cardiomyopathy Screening in Cine CMR [51.11296719862485]
  We propose a Contrastive Learning and Cross-Modal alignment framework for gadolinium-free cardiomyopathy screening using cine CMR sequences.<n>By aligning the latent spaces of cine CMR and Late Gadolinium Enhancement (LGE) sequences, our model encodes fibrosis-specific pathology into cine CMR embeddings.
  arXiv  Detail & Related papers  (2025-08-23T07:21:23Z)
• CliCARE: Grounding Large Language Models in Clinical Guidelines for Decision Support over Longitudinal Cancer Electronic Health Records [30.100759175769454]
  Large Language Models (LLMs) hold significant promise for improving clinical decision support and reducing physician burnout.<n>We propose CliCARE, a framework for Grounding Large Language Models in Clinical Guidelines for Decision Support over Longitudinal Cancer Electronic Health Records.<n>We validated our framework using large-scale, longitudinal data from a private Chinese cancer dataset and the public English MIMIC-IV dataset.
  arXiv  Detail & Related papers  (2025-07-30T10:02:16Z)
• An Agentic System for Rare Disease Diagnosis with Traceable Reasoning [69.46279475491164]
  We introduce DeepRare, the first rare disease diagnosis agentic system powered by a large language model (LLM)<n>DeepRare generates ranked diagnostic hypotheses for rare diseases, each accompanied by a transparent chain of reasoning.<n>The system demonstrates exceptional diagnostic performance among 2,919 diseases, achieving 100% accuracy for 1013 diseases.
  arXiv  Detail & Related papers  (2025-06-25T13:42:26Z)
• Intercept Cancer: Cancer Pre-Screening with Large Scale Healthcare Foundation Models [22.56012797703626]
  We present CATCH-FM, CATch Cancer early with Healthcare Foundation Models.<n>Caught-FM identifies high-risk patients for further screening solely based on their historical medical records.<n>Our analysis demonstrates the robustness of CATCH-FM in various patient distributions, the benefits of operating in the ICD code space, and its ability to capture non-trivial cancer risk factors.
  arXiv  Detail & Related papers  (2025-05-30T20:31:09Z)
• Automated Assessment of Critical View of Safety in Laparoscopic Cholecystectomy [51.240181118593114]
  Cholecystectomy (gallbladder removal) is one of the most common procedures in the US, with more than 1.2M procedures annually. LC is associated with an increase in bile duct injuries (BDIs), resulting in significant morbidity and mortality. In this paper, we develop deep-learning techniques to automate the assessment of critical view of safety (CVS) in LCs.
  arXiv  Detail & Related papers  (2023-09-13T22:01:36Z)

This list is automatically generated from the titles and abstracts of the papers in this site.

This site does not guarantee the quality of this site (including all information) and is not responsible for any consequences.